EEG Monitoring in the Emergency Department

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-06

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study seeks to investigate whether drug effects in suspected overdose patients could be identified using the electroencephalogram (EEG). From previous work it is known that different classes of anesthetic drugs have specific "EEG signatures" related to the drug mechanisms. Many of the drugs of abuse that are frequently encountered in overdose patients are similar or identical to anesthetic drugs. The hypothesis for this study is that the EEG could be used to characterize the brain effects of intoxicants using EEG in the ED setting. Such monitoring could one day help clinicians and first responders at the point-of-care make more informed decisions to improve the care of overdose patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Putting Electroencephalography (EEG) in the Emergency Department

NCT01355211

Altered Mental Status Generalized Nonconvulsive Seizure Disorder Status-epilepticus

COMPLETED

EEG Monitoring for Refractory Status Epilepticus

NCT04170491

Status Epilepticus

RECRUITING NA

Prospective Electroencephalography Evaluation of Sedation in COVID-19

NCT04815109

Conscious Sedation Pathologic Processes Electroencephalogram +2 more

COMPLETED

Putting Electroencephalography (EEG) in the Emergency Department

NCT01671475

Altered Mental Status

COMPLETED PHASE2

EEG Characteristics in ECT

NCT04022226

Electroconvulsive Therapy Direct Current Electroencephalogram Ketamine +1 more

COMPLETED EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Overdose Substance Abuse Alcohol Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational EEG Monitoring

Intervention Type OTHER

Subjects will be monitored with electroencephalogram (EEG) after arriving to the Emergency Department with suspected overdose

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational EEG Monitoring

Subjects will be monitored with electroencephalogram (EEG) after arriving to the Emergency Department with suspected overdose

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients aged 18 years and older who present to the ED with suspected use of a potential drug of abuse

Exclusion Criteria

* Hemodynamic instability or other acute medical condition for which the primary treating team does not thing it would be appropriate or safe for the study staff to approach the patient
* The patient has an overt head trauma or deformity of the face which would preclude application of the forehead EEG monitoring lead
* The patient has dermatological issues or skin conditions on the forehead
* The patient has known dementia and/or mental impairment
* The patient is a prisoner
* The patient is an employee or student at one of the study sites.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No